SSR4-CDG is an airport code for Charles de Gaulle Airport in Paris, France.

The symptoms of SSR4-CDG vary from person to person, but may include: delayed growth and development, intellectual disability, seizures, vision and hearing loss, skeletal abnormalities, and heart defects. Other symptoms may include feeding difficulties, poor muscle tone, and recurrent infections.

SSR4-CDG is a rare genetic disorder caused by a mutation in the SSR4 gene. This gene is responsible for the production of a protein called SSR4-CDG, which is involved in the formation of glycoproteins. Mutations in this gene can lead to a variety of symptoms, including developmental delays, intellectual disability, seizures, and vision and hearing problems.

The treatments for SSR4-CDG depend on the individual patient and the severity of their condition. Treatment options may include physical therapy, occupational therapy, speech therapy, dietary modifications, vitamin and mineral supplementation, and enzyme replacement therapy. In some cases, surgery may be necessary to correct physical abnormalities. Additionally, genetic counseling and support services may be beneficial for families affected by SSR4-CDG.

The risk factors for SSR4-CDG include:

1. Family history of the disorder
2. Maternal consanguinity
3. Maternal age
4. Low birth weight
5. Prematurity
6. Exposure to certain medications during pregnancy
7. Exposure to certain environmental toxins during pregnancy
8. Exposure to certain infections during pregnancy

At this time, there is no cure for SSR4-CDG. However, there are medications that can help manage the symptoms of the disorder. These medications include anticonvulsants, muscle relaxants, and anti-inflammatory drugs. Additionally, physical and occupational therapy can help improve mobility and coordination.